Company / Cash per Share
United Therapeutics Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$34.73
FY2025
5-year range
$20.10 / $36.08
FY2021-FY2025
Trend
-3.7%
vs FY2024
Sector context
#6 of 205
Health Care
What the data says
Among 205 Health Care companies, United Therapeutics is in the top 3% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $15.48 in FY2018 to $36.08 in FY2024.
Based on SEC 10-K filings.
34.73 in FY2025 with a 5-year CAGR of +15.6%. Top quartile in the Health Care sector.
Improved from $26.24 to $34.73 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +17.7%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 205This company $34.73 Sector average $72.93
▼
-52.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 3.7% year-over-year.
- Ranks #6 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2024.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.73 | -3.7% |
| FY2024 | $36.08 | +37.5% |
| FY2023 | $26.24 | +23.1% |
| FY2022 | $21.31 | +6.0% |
| FY2021 | $20.10 | +19.4% |
| FY2020 | $16.83 | -0.6% |
| FY2019 | $16.94 | +9.5% |
| FY2018 | $15.48 | -20.1% |
| FY2017 | $19.36 | -13.4% |
| FY2016 | $22.36 | +26.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026